Data / Form D filings / Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc.: Form D filings
Indaptus Therapeutics, Inc., a pharmaceuticals company in New York, NY, filed 6 Form D notices with the SEC between 2021 and 2025. The latest, on June 20, 2025, reports $2.3 million sold of a $5 million offering to 20 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3 COLUMBUS CIRCLE, New York, NY, 10019
- Phone
- (646) 427-2727
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1857044
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | New notice | $5,000,000 | $2,314,800 | $2,685,200 | 20 | Jun 12, 2025 | sec.gov |
| Jan 22, 2025 | New notice | $2,246,500 | $2,246,500 | 16 | Jan 16, 2025 | sec.gov | |
| Dec 6, 2024 | New notice | $227,127 | $227,127 | 20 | Nov 22, 2024 | sec.gov | |
| Oct 4, 2024 | Amendment | $205,480 | $205,480 | 12 | Aug 7, 2024 | sec.gov | |
| Aug 22, 2024 | New notice | $205,480 | $205,480 | 12 | Aug 7, 2024 | sec.gov | |
| Aug 5, 2021 | New notice | $30,000,000 | $30,000,000 | 1 | Jul 23, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony J. Maddaluna | Director | |
| Hila J. Karah | Director | |
| Robert E. Martell | Director | |
| Walt A. Linscott | Executive Officer | |
| Roger J. Pomerantz | Director | |
| William B. Hayes | Director | |
| Mark J. Gilbert | Director | |
| Roger J. Waltzman | Executive Officer | |
| Michael J Newman | Executive Officer, Director | |
| Jeffrey A. Meckler | Executive Officer, Director | |
| Nir J Sassi | Executive Officer |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Jun 16, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Indaptus Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.